Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oral antibiotic prophylaxis of early infection in multiple myeloma.

Next Previous
Trial Profile

Oral antibiotic prophylaxis of early infection in multiple myeloma.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciprofloxacin (Primary) ; Cotrimoxazole (Primary) ; Sulfamethoxazole (Primary) ; Trimethoprim (Primary)
  • Indications Bacterial infections; Staphylococcal infections; Streptococcal infections
  • Focus Therapeutic Use

Most Recent Events

  • 02 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 02 Nov 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
  • 30 Jun 2009 Additional lead investigator Rosenbluth RJ added as reported by New Jersey Cancer Trial Connect.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top